Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Spergel

Pediatric Allergy/Immunology Philadelphia, PA Medical Doctor

NPI 1043226996 CMS profile 137580

3550 Market St Fl 3, Children's Hospital Of Philadelphia - Allergy & Immun, Philadelphia, PA 19104

Open in the dashboard

General payments

$377,679

257 records reported · program years 2019–2025

Research payments

$78,185

Paid to them · 134 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,201,996 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jonathan Spergel of Philadelphia, PA is reported in the CMS Open Payments database as having received $377,679 across 257 general payments and $78,185 in research payments paid to them. Separately, studies naming them as principal investigator received $2,201,996 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatric Allergy/Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $73,177 31
2025 Research $5,181 11
2024 General $47,378 64
2024 Research $33,103 42
2023 General $107,404 78
2023 Research $14,045 30
2022 General $55,118 30
2022 Research $13,021 23
2021 General $38,315 16
2021 Research $8,273 13
2020 General $43,853 26
2020 Research $3,646 10
2019 General $12,435 12
2019 Research $915 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Spergel
  • Pediatric Allergy/Immunology median
  • Middle half of Pediatric Allergy/Immunology
  • National median

In program year 2025, general payments to Jonathan Spergel were reported at $73,177. Among 289 Pediatric Allergy/Immunology profiles paid that year, the median was $361 and the middle half received between $125 and $2,493.

Show as a table
Year Jonathan Spergel Pediatric Allergy/Immunology median Middle half National median
2019 $12,435 $325 $92–$1,399 $163
2020 $43,853 $144 $66–$2,490 $114
2021 $38,315 $357 $95–$2,633 $132
2022 $55,118 $385 $125–$2,259 $149
2023 $107,404 $470 $121–$2,946 $160
2024 $47,378 $317 $125–$2,583 $164
2025 $73,177 $361 $125–$2,493 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $184,757 127 payments
  2. Sanofi-Aventis U.S. LLC $31,860 11 payments
  3. Regeneron Pharmaceuticals, Inc. $31,598 20 payments
  4. Novartis Pharmaceuticals Corporation $25,790 13 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $20,420 8 payments
  6. E.R. Squibb & Sons, L.L.C. $14,358 8 payments
  7. Regeneron Healthcare Solutions, Inc. $13,569 9 payments
  8. Merck Sharp & Dohme Corporation $11,080 14 payments
  9. Eli Lilly and Company $9,200 2 payments
  10. LEO Pharma Inc. $6,665 3 payments
  11. Other $28,383 42 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $172,462 62 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $139,650 41 payments
  3. Travel and Lodging $60,257 82 payments
  4. Food and Beverage $4,595 71 payments
  5. Education $715 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $110,606 58 payments
  2. DUPIXENT Inflammation And Immunology $37,277 23 payments
  3. XOLAIR Respiratory $12,426 5 payments
  4. EBGLYSS $9,200 2 payments
  5. OPZELURA $6,567 12 payments
  6. XOLAIR Pulmonary/Respiratory Diseases $4,467 4 payments
  7. NO PRODUCT DISCUSSED $3,522 5 payments
  8. DUPIXENT Immunology And Inflammation $3,495 2 payments
  9. TEZSPIRE $3,079 15 payments
  10. FASENRA $2,626 1 payment
  11. Other $3,737 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $63,855 120 payments
  2. Pfizer Inc. $13,080 13 payments
  3. Genzyme Corporation $1,250 1 payment

Records

391 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Allergy/Immunology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record